Einstein-Mount Sinai Diabetes Research Center

Overview

The Einstein-Mount Sinai Diabetes Research Center (ES-DRC) comprises a vibrant, comprehensive, well-funded, and highly productive program that provides the foundation for high-quality and cutting-edge research in diabetes and related studies in obesity, metabolism, and endocrinology.

Animal Physiology Core

Explore

The Human Islet & Adenovirus Core (HIAC)

Explore

Stable Isotope & Metabolomics Core

Explore

Translational Research Core

Explore

Immuno-Technology Core (NEW)

Explore

Human Therapeutic Organoid Core (located at Weill Cornell Medicine)

Explore

Recent Publications

Novel Insights into the Pathogenic Impact of Diabetes on the Gastrointestinal Tract

Menopausal hormone therapy and subclinical cardiovascular disease in women with and without HIV

Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study

Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands

From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency

Contact Us

Diabetes Research Center

Division of Endocrinology  
Department of Medicine
Albert Einstein College of Medicine  
1300 Morris Park Avenue  
Bronx, NY 10461

718-430-2908

718-430-8557

Einstein-Mount Sinai Diabetes Research Center

Overview

Biomedical Cores

Animal Physiology Core

The Human Islet & Adenovirus Core (HIAC)

Stable Isotope & Metabolomics Core

Translational Research Core

Immuno-Technology Core (NEW)

Human Therapeutic Organoid Core (located at Weill Cornell Medicine)

Einstein On: Diabetes, Dr. Jeffrey Pessin (1 of 3), Causes and Current Trends

Latest News

Research by Einstein Scientists Featured in Special Issue of Diabetes Care

“Cascade of Widening Inequity” Is Accelerating the Global Diabetes Crisis

Identifying Peptides That Trigger Type 1 Diabetes

Recent Publications

Novel Insights into the Pathogenic Impact of Diabetes on the Gastrointestinal Tract

Menopausal hormone therapy and subclinical cardiovascular disease in women with and without HIV

Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study

Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands

From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency

Contact Us

Diabetes Research Center

718-430-2908

718-430-8557